![](/img/cover-not-exists.png)
THU0221 Methotrexate Optimization (IE Introduction During the First 3 Months and with Dose Escalation at 6 Months at Least at 20Mg/W or 0.3Mg/Kg/W) is Associated with Better Clinical Outcomes in Daily Practice: Results from the Espoir Cohort
Gaujoux-Viala, C., Paternotte, S., Combe, B., Dougados, M., Fautrel, B.Volume:
72
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2013-eular.749
Date:
June, 2013
File:
PDF, 269 KB
english, 2013